| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006821A1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 03/31/1994 | WO1994006820A1 Leukinferon preparation |
| 03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | WO1994006813A1 Major histocompatibility complex molecules and modifications thereof |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006469A1 Hiv fusion polypeptide |
| 03/31/1994 | WO1994006468A1 Recombinant influenza virus vaccine compositions |
| 03/31/1994 | WO1994006465A1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| 03/31/1994 | WO1994006464A1 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites |
| 03/31/1994 | WO1994006463A1 Immortalized cells and uses therefor |
| 03/31/1994 | WO1994006459A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | WO1994006456A1 Protection against liver damage by hgf |
| 03/31/1994 | WO1994006454A2 Inhibitiion of retrovirus infection |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994006450A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | WO1994006449A2 Morphogen-induced liver regeneration |
| 03/31/1994 | WO1994006447A2 60a protein-induced morphogenesis |
| 03/31/1994 | WO1994006446A1 Hepatitis a virus vaccines |
| 03/31/1994 | WO1994006445A1 Method of administering igf-1, igf-2, and analogs thereof to birds |
| 03/31/1994 | WO1994006421A1 Recombinant multivalent m protein vaccine |
| 03/31/1994 | WO1994006420A2 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | WO1994006399A1 Morphogen-induced periodontal tissue regeneration |
| 03/31/1994 | WO1994006306A1 A process for producing beta-casein enriched products |
| 03/31/1994 | WO1994006282A1 Transgenic animal models for neurodegenerative disease |
| 03/31/1994 | WO1994004693A3 Novel plants and processes for obtaining them |
| 03/31/1994 | WO1994003610A3 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 03/31/1994 | WO1994003605A3 Compositions and methods for detecting human herpesvirus 6 strain z29 |
| 03/31/1994 | WO1994003602A3 A novel human dopamine receptor and its uses |
| 03/31/1994 | WO1994002611A3 Recombinant human erythropoietin with altered biological activity |
| 03/31/1994 | WO1994002514A3 Derivatives of bauhinia purpurea lectin and their use as larvicides |
| 03/31/1994 | WO1994001548A3 Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | WO1994000489A3 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | CA2145179A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144848A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | CA2144773A1 Brain enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | CA2144767A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | CA2144651A1 Immortalized cells and uses therefor |
| 03/31/1994 | CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | CA2144515A1 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | CA2144435A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 03/31/1994 | CA2144409A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | CA2142325A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | CA2142203A1 Basophil granule proteins |
| 03/31/1994 | CA2124210A1 Fibrinogen binding protein |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
| 03/30/1994 | EP0589851A1 Transgenic non-human mammals with an oncogene under the control of an inducible liver-specific promoter |
| 03/30/1994 | EP0589841A2 Methods for the production of hybrid seed |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589719A1 Modified platelet factor-4 |
| 03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
| 03/30/1994 | EP0589487A1 Monoclonal antibodies for small organic molecules |
| 03/30/1994 | EP0589378A2 Glycosylated cytokines |
| 03/30/1994 | EP0589181A2 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 03/30/1994 | EP0589110A1 Control of ostrinia |
| 03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/30/1994 | EP0588905A1 Radiolabelled somatostatin derivatives, their preparation and use |
| 03/30/1994 | EP0588816A1 Transgenic non-human animal carrying a non-infectious hiv genome |
| 03/30/1994 | EP0321496B1 Temperature correlated force and structure development of elastin polytetrapeptides and polypentapeptides |
| 03/30/1994 | EP0245489B1 Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same |
| 03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
| 03/30/1994 | CN1084407A Method for producing clostridium perfringens vaccines |
| 03/29/1994 | US5298604 Parital primary amino acid sequence of the antineoplastic protein (ANUP); a cytokine present in granulocytes |
| 03/29/1994 | US5298603 Human granulocyte macrophage colony stimulating factor, expression in Escherichia bacteria |
| 03/29/1994 | US5298599 Fusion protein |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298492 Inhibitors of endopeptidase and treatment of cardiovascular disorders |
| 03/29/1994 | US5298491 Analytical kit |
| 03/29/1994 | US5298490 Tetra and penta-peptides useful in regulating the immune system |
| 03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
| 03/29/1994 | US5298488 Inhibiting cell adhesion and anticoagulants |
| 03/29/1994 | US5298429 Monitoring transcription of reporter gene |
| 03/29/1994 | US5298423 Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins |
| 03/29/1994 | US5298422 Myogenic vector systems |
| 03/29/1994 | US5298421 Using enzymes as tools for gene isolation and nucleic acid sequences |
| 03/29/1994 | US5298419 Diagnosis |
| 03/29/1994 | US5298410 Conjugated with superoxide dismutase protein |
| 03/29/1994 | US5298407 DNA encoding a protein active in lymphocyte-mediated cytotoxicity |
| 03/29/1994 | US5298402 Cell lines produced by transforming leukocytes of fish with oncogenes and physiologically active substances produced by the cell lines |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298395 Hyperglycosylated cytokine conjugates |
| 03/29/1994 | US5298394 Antigen-antibody reaction |
| 03/29/1994 | US5298245 Bacillus thuringiensis isolates active against dipteran pests |
| 03/29/1994 | US5298244 Proteins for immunology |
| 03/29/1994 | US5298239 Mutations rendering platelet glycoprotein IB α less reactive |